Search Results
Disruptive Technology: What New Tools & Tests Should Mean for Patients - Clifford Hudis, M.D.
Clifford A. Hudis, MD: Patient Health Records and Advancing Technology
Dr. Clifford Hudis Remarks and Q&A Intro
Dr. Clifford Hudis on Why Resistance to HER-2 Therapies Needs to be Further Researched
Dr. Clifford A. Hudis on In-Breast Response Rates in Triple-Negative Breast Cancer
Dr. Hudis Discusses the CALGB 40601 Study in Breast Cancer
Dr. Hudis Describes ASCO's CancerLinQ Program
Are randomised trials obsolete or more important than ever?
Clifford A. Hudis, MD: How Can Advocates Help Doctors?
Dr. Hudis on the Challenges of TNBC
Clifford A. Hudis, MD: Tissue Collection and Clinical Trials in Breast Cancer Research
BCRF 2010 Palm Beach Symposium 06 - Dr. Clifford Hudis Introduction
